Immediate Impact
58 standout
Citing Papers
Smart hydrogel: A new platform for cancer therapy
2025 Standout
Epigenetic drugs in cancer therapy
2025 Standout
Works of Anderson B. Collier being referenced
A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group
2018
Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Anderson B. Collier | 112 | 118 | 48 | 84 | 23 | 370 | |
| Shanthi Sivendran | 166 | 82 | 30 | 92 | 27 | 400 | |
| Wittes Re | 224 | 74 | 15 | 94 | 25 | 394 | |
| Edit Bárdi | 86 | 57 | 201 | 61 | 25 | 412 | |
| F. Cavalli | 119 | 60 | 100 | 37 | 29 | 403 | |
| Meaghan Krohe | 105 | 55 | 38 | 46 | 18 | 321 | |
| Dimple Patel | 64 | 33 | 70 | 63 | 19 | 334 | |
| Frédéríc Gomez | 155 | 213 | 35 | 80 | 22 | 408 | |
| Diane J. Fink | 146 | 53 | 53 | 39 | 18 | 385 | |
| Elizabeth L. Strevel | 138 | 81 | 21 | 110 | 16 | 403 | |
| Janna Manjelievskaia | 99 | 64 | 27 | 51 | 38 | 397 |
All Works
Login with ORCID to disown or claim papers
Loading papers...